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Abstract
Background: Glutaraldehyde fixed xenogeneic heart valve prosthesis are hindered by calcification and lack of
growth potential. The aim of tissue decellularization is to remove tissue antigenicity, avoiding the use of glutaraldehyde
and improve valve integration with low inflammation and host cell recolonization. In this preliminary study, we
investigated the efficacy of a NaOH-based process for decellularization and biocompatibility improvement of porcine
pulmonary heart valves in comparison to a detergent-based process (SDS-SDC0, 5%).
Methods: Native cryopreserved porcine pulmonary heart valves were treated with detergent and NaOH-based processes.
Decellularization was assessed by Hematoxylin and eosin/DAPI/alpha-gal/SLA-I staining and DNA quantification of native
and processed leaflets, walls and muscles.
Elongation stress test investigated mechanical integrity of leaflets and walls (n = 3 tests/valve component) of valves in the
native and treated groups (n = 4/group).
Biochemical integrity (collagen/elastin/glycosaminoglycans content) of leaflet-wall and muscle of the valves (n = 4/group)
was assessed and compared between groups with trichrome staining (Sirius Red/Miller/Alcian blue).
Secondly, a preliminary in vivo study assessed biocompatibility (CD3 and CD68 immunostaining) and remodeling
(Hematoxylin and eosin/CD31 and ASMA immunofluorescent staining) of NaOH processed valves implanted in
orthotopic position in young Landrace pigs, at 1 (n = 1) and 3 months (n = 2).
Results: Decellularization was better achieved with the NaOH-based process (92% vs 69% DNA reduction in the
wall). Both treatments did not significantly alter mechanical properties. The detergent-based process induced a
significant loss of glycosaminoglycans (p < 0,05).
In vivo, explanted valves exhibited normal morphology without any sign of graft dilatation, degeneration or
rejection. Low inflammation was noticed at one and three months follow-up (1,8 +/− 3,03 and 0,9836 +/− 1,3605
CD3 cells/0,12 mm2 in the leaflets). In one animal, at three months we documented minimal calcification in the
area of sinus leaflet and in one, microthrombi formation on the leaflet surface at 1 month. The endoluminal side
of the valves showed partial reendothelialization.
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Conclusions: NaOH-based process offers better porcine pulmonary valve decellularization than the detergent
process. In vivo, the NaOH processed valves showed low inflammatory response at 3 months and partial
recellularization. Regarding additional property of securing, this treatment should be considered for the new
generation of heart valves prosthesis.
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Background
Currently, heart valve prostheses are hindered by several
limitations. Mechanical valves have excellent long-term
durability but require lifelong anticoagulation therapy
due to thromboembolic risks. Bioprostheses do not re-
quire anticoagulation but show reduced durability and
are more prone to degeneration, particularly in younger
patients. This phenomenon has been related to a more
reactive immunity, higher calcium and phosphate me-
tabolism and physical activity that play a role in pros-
thesis calcifications [1]. Bioprosthetic valves are usually
treated with glutaraldehyde to prevent immune rejection
of the xenogeneic scaffold. But it has been early shown
that glutaraldehyde modifies mechanical properties of
the native tissue, is cytotoxic, does not remove tissue
phospholipids, induces a release of cell debris, and does
not completely suppress the immune reaction against
the graft. These events lead to chronic inflammation and
calcifications [1–5].
Finally, cryopreserved homografts with ideal
hemodynamic performance but limited availability also
show limited durability because of residual tissue im-
munogenicity [6–9]. Mechanical and bioprosthetic
valves share another disadvantage: they cannot grow and
remodel, therefore resulting in subsequent revision sur-
geries in pediatric patients [10].
Decellularization of biological valves is an alternative.
This concept involves removing all cellular components
that are supposedly immunogenic and may lead to calcifi-
cations while minimizing any adverse effect on the com-
position, biological activity, and mechanical integrity of
the matrix. The resulting extracellular matrix (ECM) can
be recellularized by the host and functionally and structur-
ally integrated into the body with growth potential [11].
As of today, new products are already commercially
available but short term results with some of those im-
plants, essentially those of xenogeneic source, did not
demonstrate convincing results in the pediatric popula-
tion [12, 13], while others, essentially decellularized
homografts from allogeneic source seemed to yield
better midterm term results [14, 15].
Despite these progresses, no gold standard decellulari-
zation process exists. Various decellularization protocols
are proposed in the literature and most popular are
those using detergents [16, 17].
We previously demonstrated enhanced biocompatibil-
ity and vascular remodeling of allogeneic and xenogeneic
pericardium with a treatment based on NaOH decellu-
larization in comparison to the glutaraldehyde fixation
and detergent process [18, 19].
This NaOH-based process has the particularity of be-
ing inactivator for conventional (virus/bacteria) and
non-conventional (prion) pathogens and therefore im-
proves the security of those grafts [20–22].
We investigated this treatment as a decellularization
process to improve biocompatibility and remodeling of
xenogeneic pulmonary heart valves for tissue engineer-
ing applications.
In vitro experiments assessed decellularization, antigen
removal, mechanical and biochemical integrity of por-
cine pulmonary heart valves treated with the NaOH-
based process (decellularized porcine pulmonary heart
valves with NaOH based-process: DPV) as well as por-
cine pulmonary heart valves treated with a conventional
detergent process (decellularized porcine pulmonary
heart valves with detergent-based process: DDPV) and
native porcine pulmonary heart valves (NPV). Moreover,
an in vivo preliminary study was conducted to assess
biocompatibility (inflammation and calcifications) and
remodeling (endothelialization and recellularization) at 1
and 3 months follow-up of DPV valve in a growing allo-
geneic/porcine model.
Methods
Sources of matrices
For in vitro study, porcine Landrace hearts were procured
from a local slaughterhouse (Eurovlees, Zele, Belgium).
For in vivo study, porcine hearts were procured at our la-
boratory, from Landrace pigs weighing 20 kg, used for ab-
dominal surgery course/demonstration. Animals were
euthanized, and hearts harvested respecting the standards
of animal care. The pulmonary valves were then harvested,
rinsed with sterile ringer solution and frozen at − 80 °C.
Matrix preparation
Before processing, valves were thawed and washed in
sterile ringer solution.
Two treatment protocols were conducted. The
detergent-based process was based on a conventional
detergent protocol previously published. Briefly, porcine
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pulmonary valves were incubated for 48 h in an aqueous
solution containing 0.5% sodium deoxycholate (SDC)
and 0.5% sodium dodecyl sulfate (SDS) under continu-
ous agitation followed by a 72 h rinsing step in a con-
tinuous flow of demineralized water [23, 24].
As previously described, the NaOH-based process con-
sists of a succession of baths of acetone, ethanol, NaOH
and Hydrogen Peroxyde. This chemical treatment ensures
defatting, prions/viruses and bacterial inactivation [18].
Finally, the valves (Fig. 1a) were frozen at − 80 °C
without solution and individually packed.
In vitro characterization
Valves were individually characterized for leaflet, pul-
monary trunk (wall) and muscle structure.
For histological assessment, the valves were cut longi-
tudinally to explore wall, leaflet and muscle on the same
slide (Fig. 1b). The slices were immediately fixed over-
night in 4% formaldehyde and embedded in paraffin.
Serial sections (thickness of 5 μm) were mounted on
glass and dried for 12 h at 37 °C.
Hematoxylin and eosin and DAPI staining
Decellularization was evaluated first by Hematoxylin
and eosin (HE) and 40.6-diamidino-2-phenylindole
(DAPI; 1 μg/ml/Abbot Molecular Inc-USA) staining.
These two methods reveal the nuclei. Sections from 4
different valves per condition (NPV, DPV, DDPV) were
stained and slides were then digitalized using a SCN400
slide scanner (Leica Biosystems, Wetzlar, Germany) at
20× magnification for HE. For DAPI assessment,
samples were photographed at high definition under
structured illumination using a Zeiss AxioImager-
Apotome system.
Antigen removal
The presence of residual antigens such as alphagalacto-
syltransferase antigen (alpha-gal) and swine leucocyte
antigen class 1 (SLA-1: the major histocompatibility
complex class1 region of pigs) were investigated by im-
munohistochemistry. Four valves per condition (NPV,
DPV, DDPV) were analyzed. After deparaffinization, en-
dogenous peroxidases were inhibited during a 20-min
methanol bath with 3% hydrogen peroxide. Primary anti-
bodies (mouse anti-SLA class Ic (1:200; 16.7. E4.2: IgM)
[25]); mouse anti-alpha galactose, M86, Enzo Life Sci-
ences®) were revealed with the corresponding Envision
HRP-coupled antibodies (Dako) and Diaminobenzidine
staining. After counterstaining with hematoxylin, slides
were dehydrated and mounted. Stained slices were then
digitalized using a SCN400 slide scanner (Leica
Biosystems, Wetzlar, Germany) at 20× magnification.
DNA quantification
DNA was extracted with DNeasy® Blood & Tissue Kit
(QIAamp DNA Mini Kit, QIAGEN, Hilden, Germany).
Three valves per condition were used and one sample
per valve region was processed. Extracted DNA was
quantified by Quant-it Picrogreen DNA assay kit
(Invitrogen, CA, USA), according to manufacturers’
c
a b
d
Fig. 1 Valve characterization: methods. a: macrophotograph of a DPV. b: microphotograph of NPV after trichrome staining illustrating histological
assessment of the valves in 3 zones:1: the muscle/2: the leaflet/3: the wall. Scal barr: 1 mm. For histological evaluation, the explanted valves were
sectioned in six segments (c) to analyze the three zones (d)
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protocol. Fluorescence was read at 480 nm and
520 nm. Final DNA concentration was expressed in
ng/mg dry weight.
Mechanical properties
Uniaxial mechanical resistance tests were performed on a
minimum of four valves per condition on the three leaflets
and three samples of pulmonary wall per valve. Samples
of 15 mm on 15 mm for wall and the whole leaflets were
placed between two plastic structure with a central hole of
8,5 mm diameter where a probe comes in contact and ap-
plies pressure on the tissue. Mechanical testing was per-
formed, using an Instron traction system with Instron
bluehill software (Model 5600, Instron, Canton, MA) with
a load-to-failure test set at an elongation rate of 3 mm.
min− 1. The load to elongation behavior of the matrices
and failure modes were recorded. The structural
properties of the matrices were represented by stiffness
(Nm.m− 1) and ultimate load (N). Stiffness (k) was
calculated as k =ΔF/ΔL where, F is the force applied on
the body and L is the displacement produced by the force
along the same degree of freedom. These parameters were
compared between native and treated tissues. Tests were
not conducted on muscle.
Biochemical integrity
Longitudinal slices from 4 different valves per condition
(NPV, DPV, DDPV) were analyzed. Five micrometer sec-
tions were stained using a combined Miller, alcian blue
and sirius red trichrome, as described by Sarathchandra
P. [26]. The Miller stains elastin in dark blue, the alcian
blue colors the glycosaminoglycans (GAGs) in Cyan and
the sirius red stains collagen in red.
Quantification was performed individually on leaflet,
pulmonary wall and pulmonary trunk using Tissue IA
software (Leica Biosystems, Dublin, Ireland). Pixels
corresponding to the Miller, Alcian blue and Sirius red
staining were selected separately to create three color
profiles. Total tissue area was defined by setting an in-
tensity threshold (grey value). Results were expressed as
a percentage of stained area and calculated as (stained
area/tissue area) × 100.
In vivo study
Surgical procedure
Animals were housed according to the guidelines of the
French Ministry of Agriculture and Animal Care. All
procedures were approved by the local Ethics Commit-
tee for Animal Care of the Ecole de Chirurgie - Univer-
sité de Lorraine, Nancy (D57–547-5).
Three female Landrace pigs weighting 40 kg were kept
unfed for 24 h before the operation. A premedication of
ketamine (1000 mg) was administered by IM. The ani-
mals were then intubated and kept under general
anesthesia throughout the operation. A physiological
follow-up (oximetry, pulse, and heart rate) was con-
ducted throughout the entire operating procedure. After
longitudinal sternotomy, the heart was exposed.
Systemic heparinization was achieved with an activated
coagulation time of 400 s. Pediatric cardiopulmonary by-
pass was then placed and turned on. Then, the native
pulmonary artery root was harvested and replaced with
DPV with two 5.0 prolene running sutures. After im-
plantation, the pigs were weaned off bypass. The cannu-
las were removed and the sternum was closed. The pigs
received low molecular weight heparin prophylaxis
(40 mg/day) for 5 days. The animals did not receive anti-
biotics. One pig was euthanized at day 30 and 2 pigs
were euthanized at day 90. The valves were then re-
moved and cut in order to obtain three parts relating to
posterior, right and left leaflets and the corresponding
sinus, pulmonary wall and muscular base. Finally, these
portions were divided in two parts to obtain six seg-
ments (Fig. 1c/d). Tissues were fixed overnight in 4%
formaldehyde and embedded in paraffin.
Histological evaluation
Coloration and staining Hematoxylin and eosin, Mas-
son’s trichrome and von Kossa stainings assessed remod-
eling/cell infiltration, structure and calcifications
respectively.
Immunohistochemistry for CD3 and CD68 were per-
formed using a Ventana Benchmark XT machine
(Roche®, USA) to assess inflammatory reaction. The CD
68 is particularly useful as a marker for the various cells
of the macrophage lineage, including monocytes, histio-
cytes, giant cells, Kupffer cells. CD3 is highly specific of
all stages of T-cell development [18]. Slides were digita-
lized at 20× magnification with a SCN400 slide scanner
(Leica, Wetzlar, Germany) and visualized on the Digital
Image Hub (Leica Biosystems, Dublin, Ireland).
For immunofluorescent co-staining, 5 μm sections
were subjected to endogenous peroxidases inhibition
for 20 min and then to specific antigen binding sites for
1 h (PBS with 5% BSA and 0.05% Triton). Rabbit anti-
CD31 (polyclonal, Abcam, # ab28364, 1/100 dilution
for rat, 1/50 dilution for pig) and Mouse anti-ASMA
(clone 1A4, Abcam #ab7817, 1/100 dilution, for pig),
primary antibodies were incubated overnight at 4 °C in
PBS containing 1% BSA and 0.05% Triton X-100. This
was followed by an incubation with AlexaFluor 568
anti-rabbit and AlexaFluor647 anti-mouse (Invitrogen)
secondary antibodies, incubated at a 1/1000 dilution for
1 h at room temperature. Nuclei were stained with
DAPI and labeled sections.
Stained sections were digitized using a Pannoramic
P250 FlashIII slide scanner (3DHistech) at 20× magnifi-
cation and visualized using CaseViewer.
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Histomorphometry A minimum of five regions of inter-
est [ROI] in the three parts (wall/leaflet/muscle) of the
six segments of the explanted DPV were analyzed at ×
20 magnification with a grid representing a surface of 0.
12 mm square. CD3 and CD68 immunohistochemical
staining’s were assessed by point counting as previously
described [18].
Statistical analysis
One-sample Kolmogorov–Smirnov tests and QQ-plots
were used to ensure the normal distribution of values.
Results were expressed as means ± SD or in ratios. The
statistical significance of differences between experimen-
tal groups was tested by Student-T or one-way analysis
of variance with a Bonferroni’s post hoc test. The statis-
tical tests were carried out with PASW 18. Differences
were considered to be significant at p < 0.05.
Results
In vitro characterization
Decellularization and antigen removal
Staining for HE, DAPI and alpha-gal and SLA-I was
positive for controls in the three parts of the valve.
Decellularization and antigen removal were more
complete for DPV than for DDPV as well for the muscle,
wall or leaflet of treated valves. Positive staining for
alpha-gal and SLA-I were still detected for DDPV in the
three parts. Cells were also evidenced with hematoxylin
and eosin for DDPV muscle and wall (Fig. 2/Table 1).
Mechanical integrity
No differences between NPV, DPV and DDPV regarding
elasticity and maximal load of leaflets or pulmonary wall
were detected (Fig. 3a).
DNA
Better DNA reduction was achieved with NaOH-based
process in comparison with detergent process. The DPV
leaflets showed 95% DNA reduction to NPV while
DDPV showed 92% DNA reduction. In the wall of
DDPV, DNA content was reduced to 69% and in the
DPV, the content was reduced to 92%. In the muscle,
DNA reduction was quite similar for both treatments:
96% for DDPV vs 97% for DPV (Fig. 3b/Table 2).
Biochemical integrity
Muscle Collagen and elastin staining were maintained
in DPV and DDPV in comparison to NPV. However, sig-
nificant reduction of GAGs staining in DDPV muscle in
comparison to NPV occurred (p = 0.021) while there was
no difference between DPV and NPV (Fig. 4).
Leaflet Histological examination after trichrome stain-
ing revealed evidence of GAGs staining reduction after
both treatments. Software analysis showed GAGs stain-
ing was significantly reduced for both DPV and DDPV
to NPV with p < 0.05 while elastin staining was signifi-
cantly reduced for DDPV to NPV (p = 0.021).
Collagen staining was not reduced after both treat-
ments (Fig. 4).
Wall No significant reduction of staining was noticed
for DPV and DDPV in comparison to NPV (Fig. 4).
In vivo study
No deaths occurred. The three pigs showed regular growth
(to reach 60 kg at 1 month and 120 kg at 3 months).
Macroscopic evaluation
The explanted valves exhibited no signs of graft dilata-
tion, degeneration or rejection. The luminal surface of
the arterial wall was similar to the adjacent host artery.
At 1 month, the DPV exhibited two translucent, flex-
ible and mobile leaflets while one small thrombus was
detected in the third one (Fig. 5a1).
At 3 months, all leaflets of the two DPVs were translu-
cent, flexible and mobile. We noticed one calcification
in one posterior leaflet sinus (Fig. 5a2).
Histological evaluation
Inflammation CD3 infiltration was essentially located in
the muscle at 1 month. The CD3 count was significantly
the lowest in the leaflets (p < 0,005). At 3 months, the
CD3 infiltration showed the same repartition than at
1 month with the highest count in the muscle with p <
0,05. At 3 months in comparison to 1 month, infiltration
was significantly reduced in the wall and in the muscle
with p < 0,005 while leaflet infiltration was still low (0,98
+/− 1,36 cells/0,12 mm2) (Fig. 5b/c).
At 1 month CD68 infiltration was low in all parts of
the valves with the highest count in the muscle part with
p < 0,05. The lowest count was in the leaflets (p < 0,05).
At 3 months, the CD68 infiltration was still the lowest
in the leaflet with p > 0,05 but not statistically different
than in the wall and in the muscle. The CD68 infiltra-
tion significantly decreased at 3 months in the muscle
(p = 0,000) (Fig. 5c).
Calcifications Von Kossa staining was positive for one
sinus at 3 months.
Remodeling HE, AMSA and CD31 staining showed
progressive DPV recellularization occurred at one and 3
months (Fig. 6). The interstitial recellularization in-
creased with time and cell colonization, was deeper in
the pulmonary trunk at 3 months than at 1 month but
was still partial (Fig. 6a). In a similar way,
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endothelialisation (endothelial cell monolayer) of DPV
was still partial at 1 month and 3 months (Fig. 6b).
Discussion
The aim of the present study was firstly to assess the ef-
ficacy of a NaOH-based process to decellularize and
maintain biochemical and mechanical properties of
xenogeneic valve in comparison to a standard detergent
treatment. This treatment, a combination of 0.5%SDC
/0.5%SDS is largely recommended for xenogeneic tissues
decellularization as for human valves decellularization
with good midterm clinical results in pediatric and adult
populations [14, 23, 27–29]. Secondly a preliminary
Fig. 2 Histological valves characterization: Hematoxylin and eosin/DAPI/Alpha-gal and SLA-1 staining. Representative histology microphotograph
of muscle (first table)/leaflet (second table) and wall (third table) of NPV (first line), DPV (second line) and DDPV (third line) after Hematoxylin and
eosin (HE, first column), DAPI (second column) Alpha-gal (third column) and SLA-1 (fourth column) staining. (Black scale bar: 100 μm and white
scale bar: 200 μm). The black arrows show positive staining. The staining for NPV (both muscle/leaflet and wall) was positive in all conditions (HE/
DAPI/Alpha-gal and SLA-1) and was clear
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study investigated in a growing model biocompatibility
and remodeling/cell recolonization of NaOH-based
processed valve.
The main decellularization agent of our treatment is
NaOH. The duration of exposure of the tissue to this
agent and the combination with other chemicals offer a
supplementary property to inactivate conventional
(bacteria and virus) and non-conventional (prion) patho-
gen agents that a conventional detergent process does
not offer, improving grafts security [22]. To our
knowledge, this method for valve decellularization was
not yet reported. The NaOH, while known as a decellu-
larization agent, is not commonly used for biological tis-
sue decellularization because it is at risk to denature the
tissue. Indeed, decellularization treatments have to re-
spect a perfect balance between decellularization and
maintenance of physical properties for optimal in vivo
functionality [30, 31]. Our in vitro and in vivo results
showed the treatment did not denature the valves and
can also ensure this balance for very thin structures such
as leaflets.
Moreover, our treatment achieved better results in
terms of decellularization and antigen removal than the
detergent-based process. The presence of alpha-gal epi-
tope remaining should lead to rapid deterioration of the
last in a clinical scenario as it was observed for
Synergraft valves [12, 32].
The NaOH-based process led to lower biochemical
modifications of the valves in comparison to detergent
treatment while mechanical properties of detergent-
based processed valves were maintained.
It was shown that SDS might destabilize the triple hel-
ical domain of collagen and lead to tissue deterioration
[33–35]. We noted the use of SDS lead to extracellular
matrix swelling due to destruction of extracellular gly-
cosaminoglycans as in our study while we did not ob-
serve direct consequences on mechanical tests not
altered in comparison to native valves.
Table 1 Assessment of HE/DAPI/Alpha-gal and SLA-1 stainings
for muscle/leaflet/wall of control (NPV, n = 4), DPV(n = 4) and
DDPV(n = 4)
H.E. DAPI Alpha-gal SLA-1
Muscle NPV +++ +++ +++ +++
DPV – – – +
DDPV + – + ++
Leaflet NPV +++ +++ +++ +++
DPV – – – –
DDPV – – + –
Wall NPV +++ +++ +++ +++
DPV – – – –
DDPV + + + ++
Semi-quantitative numerical scale: –: no staining; +: staining traces; ++: moderate
staining and +++: intense staining
a
b
Fig. 3 Valves characteristics: Mechanical properties and DNA content. a: Stiffness (K: N/mm) and maximal load before rupture (F max: Newton) of
leaflet and wall of NPV, DDPV and DPV. No significant differences were observed between groups. b: DNA content (ng/mg) in muscle, leaflet and
wall of NPV, DDPV and DPV
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Table 2 DNA content (ng/mg) in NPV, DDPV, DPV and DNA reduction in DDPV and DPV
Native (n = 3) DDPV (n = 3) DPV (n = 3)
Total DNA (ng/mg) Total DNA (ng/mg) % reduction Total DNA (ng/mg) % reduction
Muscle 730,58+/−223,20 31,02+/− 20,07 96% 23,35+/− 18,92 97%
Leaflet 1345,65+/−100,64 110,3231+/−85,27 92% 77,16+/−7,94 95%
Wall 1278,85+/− 332,05 396,60+/−196,30 69% 122,34+/−23,52 92%
a
b
Fig. 4 Biochemical valves characterization. a: Table of representative histologic microphotographs of the three parts (muscle/leaflet and wall) of
NPV (first column), DPV (second column) and DDPV (third column) after trichrome staining. Scale bar: 100 μm. Note reduction of blue staining
(GAGs) in treated leaflets (*: DPV leaflet and **: DDPV leaflet) while coloration of wall in the different conditions are quite similar. b: Quantification
of staining area for Sirius red (collagen), Miller (elastin) and Alcian blue (GAGs) /analyzed tissue area in muscle (first line) /leaflet (second line) and
wall (third line) of NPV, DPV and DDPV after trichrome staining. *: p < 0.05
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Additional studies also showed that the cytotoxicity of
SDS can have an influence on the ingrowth of host
valvular endothelial and interstitial cells [6, 36].
On the contrary, the NaOH-based process showed
previously good clinical results regarding biocom-
patibility and cytotoxicity for other allogeneic bio-
logical tissues in different implantation sites with
good host cell incorporation and remodeling [18, 19,
37, 38].
Our in vivo study confirmed this aspect. The in vivo
results showed very low inflammation while the leaflets
were thin and translucent at 3 months. Moreover, a
recellularization, which is also of major concern for
decellularized scaffolds integration and function,
a
b
c
Fig. 5 DPV in vivo results: macroscopic assessment and CD3/CD68 infiltration. a: Macroscopic views of explanted valves at one month (1) and
three months (2) follow-up. The forceps indicate translucent and flexible leaflets. The black arrow in 1 shows thrombi formation and in 2, a micro
calcification in the posterior sinus. b: Representative histological findings of CD3 staining of DPV at one month (first line) and three months
(second line) of follow-up in leaflet (1;4), wall (2;5) and muscle (3;6). Note staining was the highest in muscle at one month (3) and reduction of
staining at three months in comparison to one month (1- > 4 for leaflets/2- > 5 for wall and 3- > 6 in muscle). Scale bar: 100 μm. c: Results of
histomorphometry for CD3 (first line) and CD68 (second line) staining in the three portions of DPV at one month and three months showing a
decrease of inflammatory reaction at three months in all portions of the valve and significantly (*: p < 0,05) in wall and muscle portions for CD3
infiltration and in wall portion for CD68 infiltration. Low inflammation in the leaflet, the wall and muscle portions was found at 3 month: for CD3
infiltration: respectively 0,98 +/− 1,36; 3,1+/− 3,28 and 5,08 +/− 4,35 cells/0,12 mm2. and for CD68 infiltration: respectively CD68: 0,32 +/− 0,69; 0,93
+/− 1,44 and 0,87 +/− 1,34 cells/0,12mm2)
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occurred and was progressive but still partial at 3
months. This phenomenon was also observed by others
and a longer follow-up will investigate if complete recel-
lularization can be achieved [39].
Another crucial point for cardiovascular prosthesis
assessment is calcification occurrence. In this aspect,
of the three implanted valves, in this growing model
we observed one calcification focus in a sinus at 3
months. One explanation is although histologic exam-
inations showed adequate decellularization and anti-
gen removal, DNA quantification revealed only 92%
DNA reduction in comparison to native in this re-
gion. This is less than the recommended threshold of
95% DNA reduction as nulceic acid can act as nucle-
ation sites for calcifications [1, 16]. Unfortunately, a
link is difficult to establish due to the small sample
which constitutes a limit in our study.
Additionally, acetone and ethanol are part of the
process. As detergents, these chemicals are recognized
as antimineralization agents in heart valve substitutes by
removal of phospholipids and cholesterol [1, 40–42].
Alcohols also aid in tissue decellularization by dehy-
drating and lysing cells. However, alcohol and acetone as
tissue fixatives can damage ECM ultrastructure. In com-
parison to detergent treatments, acetone and alcohol
crosslink ECM can produce stiffer scaffolds with mech-
anical properties further removed from those of native
tissue [16]. We did not observe this phenomenon and
conclude the proposed dilutions and duration of tissue
exposure are not deleterious.
a
b
Fig. 6 In vivo DPV Remodeling. a: Representative histological findings of Hematoxylin and eosin staining of DPV Leaflet (1,3) and Wall (2,4) of at
one month (1;2) and three months (3;4) of follow-up illustrating the recellularization process. The black arrows indicate cell nuclei. Scale bar: 100 μm. b:
Representative histological findings of CD31 (red) and ASMA (white) IHF stainings counterstained with DAPI (blue) of NPV leaflet (1), DPV leaflet at one
month (2) and DPV leaflet at three months (3). Scale bar: 100 μm. The yellow arrows indicate CD31 + cells and white arrows DAPI + cells
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Last, the preservation method that we used is simple, cost
effective, and the valve can be easily stored and banked for a
long time as musculo-skeletal tissues in a tissue bank [18].
The results of this preliminary study are encouraging
to consider this NaOH-based process for xenogeneic
valve decellularization. In the clinical setup, xenogeneic
source is advantageous regarding availability. But xeno-
geneic tissue transplantation to humans imposes high
caution in view of controversial results with xenogeneic
decellularized gafts [12]. We investigated only alpaha gal
epitope removal. Others xeno non alpha-gal antigens
exist and especially a recently highlighted, highly im-
munogenic xenoantigen, N-glycolylneuraminic acid anti-
gen. This should be also investigated. The new
genetically modified pigs for these major xenoantigens
(alphagalactosyltransferase KO N-glycolylneuraminic
acid KO pigs) offer new possibilities in this direction
[43]. On the other hand, it would be impossible and in-
appropriate to check the disappearance of all xeno anti-
gens [44] and, as suggested by G Gerosa, a step back to
the preclinical evaluation in human-like models (non-
human primates) is mandatory to assess effective
biocompatibility [17].
Moreover, larger samples with a longer follow-up and
echocardiographic data are prerequisite before consider-
ing clinical translation.
Conclusions
The NaOH-based process does not alter biomechanical
valve properties and can be used for xenogeneic heart
valve decellularization. It ensures better decellularization
and antigen removal than detregent-based process. In a
preliminary in vivo study, the NaOH-based processed
valve showed recellularization, low inflammation, and
absence of structural deterioration. Regarding additional
property of graft securing, this treatment should be con-
sidered for the new generation valves.
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